index - Myasthenia Gravis: étiologie, physiopathologie & approches thérapeutiques Accéder directement au contenu

Dernières publications

Chiffres clés

56 Publications avec texte intégral

Open Access

46 %

Mots clés

Lamin A/C nuclei Early-onset myasthenia gravis Chronicity B cells COVID-19 Quality of life Neuromuscular junction BAFF Immune regulation Exercise Genetic associations Centres germinatifs ectopiques Macrophages Mass cytometry CyTOF FMR1 Germinal centers CXCL13-CXCR5 Transcriptome Inflammatory cytokines COX2 Human myoblasts Myasthenia Gravis MG Antimir-150 Long-term follow-up Glucocorticoids AChR antibodies Experimental models Disease susceptibility Myasthénie grave CCL21 Ectopic germinal centers Age Il-23 Acides nucléiques endogènes Cardiomyopathy Adaptive immunity Acetylcholine receptors Innate immunity Autoimmunity Inflammation Neuromuscular junction Germinal centers Th17 Muscle regeneration Chronic inflammation Autoimmunity Interferon de type I Myoblasts Interferon-β Autoimmune diseases Interferon IFN Thymus Immunity CTCF Auto-immunité Cellules th17 Thymic epithelial cells PBMC Chemokine CD31 Immunology and Microbiology Section Immune response Interleukin 23 Gender Etiology Aldehyde dehydrogenase biological marker CD31 antigen CD34 antigen CD45 antigen CD56 antigen adipocyte animal experiment animal model animal tissue antigen expression article cell differentiation cell function cell isolation cell labeling cell population cell selection controlled study endomysium enrichment culture enzyme activity enzyme substrate flow cytometry human human cell human tissue immunofluorescence in vitro study in vivo study mouse muscle biopsy muscle contraction muscle injury nonhuman phenotype skeletal muscle stem cell transplantation Adipogenesis Aldehyde Dehydrogenase Cell Differentiation Cells Cultured Flow Cytometry Humans Immunohistochemistry Muscle Cells Muscle Development Muscle Skeletal Phenotype Interferonopathy Follicular hyperplasia Chemokines Germinal center Gd T cells MG patients Acetylcholine receptor antibodies Interleukine-23 Experimental mouse models Th17 cells Maladie auto-immune Autoimmune disease Experimental autoimmune myasthenia gravis EAMG Interferon Ferrites Genetics LMNA Fragile X syndromes Inflammation Interferon type I Interféron de type I Interferon type-I Myasthenia gravis Clinical cell transplantation Animal models Conduction disease M3243AG Cytokines Immunotherapy Anticorps monoclonal Experimental autoimmune myasthenia gravis Thymoma Complete Freund's adjuvant Max Heart failure DICER Acetylcholine receptor MYB Endogenous nucleic acids